Ammonium Hydroxide → HCID 58486287, compound
Reaction equation
C([O:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[CH:16]=[CH:15][C:14]([C:17]3[C:25]4[C:20](=[CH:21][C:22]([C@H:26]5[C@@:28]6([C:36]7[C:31](=[CH:32][CH:33]=[C:34]([O:37][CH3:38])[CH:35]=7)[NH:30][C:29]6=[O:39])[CH2:27]5)=[CH:23][CH:24]=4)[NH:19][N:18]=3)=[CH:13][N:12]=2)[CH2:7][CH2:6]1)(=O)C.[NH4+].[OH-]>CO>[OH:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[N:12]=[CH:13][C:14]([C:17]3[C:25]4[C:20](=[CH:21][C:22]([C@H:26]5[C@@:28]6([C:36]7[C:31](=[CH:32][CH:33]=[C:34]([O:37][CH3:38])[CH:35]=7)[NH:30][C:29]6=[O:39])[CH2:27]5)=[CH:23][CH:24]=4)[NH:19][N:18]=3)=[CH:15][CH:16]=2)[CH2:7][CH2:6]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 1-(5-(6-((1R*,2S*)-5′-methoxy-2′-oxospiro[cyclopropane-1,3′-indoline]-2-yl)-1H-indazol-3-yl)pyridin-2-yl)piperidin-4-yl acetate (40 mg, 0.076 mmol) and aqueous NH4OH (0.03 mL, 14 M) in MeOH (3 mL) was stirred at rt for 17 h. The crude reaction mixture was concentrated under reduced pressure to dryness, and the resulting crude product was purified by preparative HPLC to give the title compound as a yellow solid and as the TFA salt (23 mg, 62%). 1H NMR (400 MHz, MeOD) δ 8.56 (dd, J=9.6, 2.0 Hz, 1H), 8.37 (d, J=1.6 Hz, 1H), 7.86 (d, J=8.5 Hz, 1H), 7.54 (s, 1H), 7.49 (d, J=9.6 Hz, 1H), 7.05 (d, J=8.5 Hz, 1H), 6.83 (d, J=8.4 Hz, 1H), 6.60 (dd, J=8.4, 2.4 Hz, 1H), 5.60 (d, J=2.3 Hz, 1H), 4.06-3.99 (m, 3H), 3.65-3.59 (m, 2H), 3.37-3.35 (m, 1H), 3.28 (s, 3H), 2.26-2.23 (m, 1H), 2.20-2.16 (m, 2H), 2.09-2.04 (m, 2H), 1.78-1.69 (m, 2H); MS ESI 482.3 [M+H]+, calcd for [C28H27N5O3+H]+ 482.21.
Workup
- customThe crude reaction mixture
- concentrationwas concentrated under reduced pressure to dryness
- customthe resulting crude product was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-a33aeba930044e158f8478c4ee92fdfc
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09139563B2
Reaction notes
Loading…